Back to Search Start Over

A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients

Authors :
Ungsedhapand, Chaiwat
Kroon, Eugene D.M.B.
Suwanagool, Surapol
Ruxrungthan, Kiat
Yimsuan, Nongluk
Sonjai, Areerat
Ubolyam, Sasiwimol
Buranapraditkun, Supranee
Tiengrim, Surapee
Pakker, Nadine
Kunanusont, Chaiyos
Lange, Joep M.A.
Cooper, David A.
Phanuphak, Praphan
Source :
Journal of Acquired Immune Deficiency Syndromes (1999). June 1, 2001, Vol. 27 Issue 2, p116, 8 p.
Publication Year :
2001

Abstract

Three nucleoside reverse transcriptase inhibitors appear to be better than two, according to a study of 106 HIV patients who took zidovudine and lamivudine or zidovudine, lamivudine, and didanosine.

Details

ISSN :
15254135
Volume :
27
Issue :
2
Database :
Gale General OneFile
Journal :
Journal of Acquired Immune Deficiency Syndromes (1999)
Publication Type :
Academic Journal
Accession number :
edsgcl.76330513